HDAC1 and neoplasm: Multiple studies have recently reported that HDAC1 has become a promising anticancer target since HDAC inhibitors can induce tumor cell apoptosis and inhibit angiogenesis.[41] Therefore, inhibition of HDAC signaling may result in broad disturbances in normal cellular functions.